Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases

March 21, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., March 21, 2011 /- Beginning April 1, Highmark Blue Cross Blue Shield (Highmark) will force a number of their insured patients with primary immunodeficiency diseases and other rare disorders to switch their prescription to a single brand of immunoglobulin (IgG - a blood...

OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation

March 21, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, March 21, 2011 /- OrbusNeich today announced that it has filed a lawsuit in the Netherlands against Dr. Pavel Cervinka and Masaryk Hospital in Usti nad Labem, Czech Republic, where Dr. Cervinka is head of the hospital's Cardiology Department. The suit relates to a clinical...

A Smoking Gun for Emphysema

March 20, 2011 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A new blood test may detect signs of the disease before symptoms appear.

Advertisement

New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies

March 19, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

KING OF PRUSSIA, Pa., March 19, 2011 /- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with a...

Covidien Announces FDA Advisory Committee Unanimously Recommends Approval for Pipeline(TM) Embolization Device

March 18, 2011 7:35 pm | by Covidien | News | Comments

MANSFIELD, Mass., Mar 18, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel voted to recommend approval for Pipeline(TM) Embolization Device,...

BridgePoint Medical Names Industry Veteran as Chief Executive Officer

March 18, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, March 18, 2011 /- BridgePoint Medical, Inc., a Minnesota based medical device company, has announced that Denis Harrington has joined the company as President and Chief Executive Officer.  A seasoned medical device executive with nearly two decades of experience in the...

Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Countingâ??Tells their Life-Saving Story to Media on March 18, 2011

March 18, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

FLINT, Mich., March 18, 2011 /PRNewswire-USNewswire/ -- The Aeschliman family of Midland, Michigan have a new lease on life. Nancy Aeschliman Grau and her three children—Katie, Chris, and Mike ALL underwent Roux-en-Y bariatric surgery at Hurley Medical Center—the first...

Giant Eagle® Receives American Diabetes Association Chairman's Citation Award

March 17, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, March 17, 2011 /- Giant Eagle®, the region's leading food and fuel retailer, has received the American Diabetes Association's (ADA) prestigious Chairman's Citation Award. Giant Eagle is the second ever recipient of the Award, which recognizes the outstanding...

Advertisement

Amarin Reports Year-End and Q4 2010 Results

March 17, 2011 5:31 am | by Bio-Medicine.Org | News | Comments

DUBLIN and MYSTIC, Conn., March 16, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company focused on cardiovascular disease, today reported financial results for the fiscal year and fourth quarter ended December 31, 2010. The Company also provided an...

New Highmark Policy Threatens Pennsylvania Patients With Primary Immunodeficiency Diseases

March 16, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., March 16, 2011 /- Beginning April 1, Highmark Blue Cross Blue Shield (Highmark) will force their insured patients with primary immunodeficiency diseases (PIDD) and other rare disorders to switch their prescription to a single brand of immunoglobulin (IgG - a blood plasma...

Global Blood Processing Supplies And Equipment Industry

March 16, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 16, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Blood Processing Supplies And Equipment Industry http://www.reportlinker.com/p087335/Global-Blood-Processing-Supplies-And-Equipment-Industry.html This report...

Aegerion gains orphan drug status for lipid disorder drug

March 16, 2011 10:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Aegerion Pharmaceuticals Inc., a lipid disorder treatment firm in Cambridge, has been granted orphan drug designation from the U.S. Food and Drug Administration for its treatment of familial chylomicronemia (FC), a rare genetic disorder.

Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray

March 16, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

CRANFORD, N.J., March 16, 2011 /- Coronary artery disease (CAD), also known as coronary heart disease, is the most common type of heart disease, currently affecting about 17 million Americans(1). Most of these people suffer from a common symptom of CAD known as angina pectoris. For over...

Advertisement

BD Donates $325,000 for Japan Earthquake and Tsunami Relief Efforts

March 15, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., March 15, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it is donating $325,000 to assist in relief efforts for victims of the earthquake and tsunami in Japan. BD will distribute these funds...

Electricity Sparks Interest in New Technologies and Cosmeceuticals for Aging Skin

March 15, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

SCHAUMBURG, Ill., MARCH 15, 2011/PRNewswire-USNewswire/ -- It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of...

FDA Approves Gadavist for Central Nervous System Scans

March 15, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., March 15, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system. (Logo:...

Pradaxa Gains Preferred Formulary Status with Key Pharmacy Benefit Managers

March 14, 2011 1:33 pm | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn., March 14, 2011 /- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), today announced that Pradaxa® (dabigatran etexilate mesylate) capsules has received preferred Tier 2 formulary status with CVS Caremark (Commercial Preferred Drug List) and Medco (Commercial...

New Aid for AIDS - ICAP Ocean Tomo Announces Auction of a Keystone Patent for Cell Therapy Use of Modified Red Blood Cells for Treating Viral Diseases

March 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

CHICAGO, March 14, 2011 /- Developed by inventor Lawrence F. Glaser and represented by ICAP Ocean Tomo , this technology will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. (Logo:  ...

OrbusNeich Announces Availability of Azuleâ„¢ Cobalt Chromium Stent

March 14, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, March 14, 2011 /- OrbusNeich today announced the launch of the CE marked Azule Cobalt Chromium Stent.  The Azule Stent combines the proven stent design of its predecessor, the company's Blazer™ Cobalt Chromium Stent, with a delivery system with enhanced crossability...

Transgenomic Expands COLD-PCR License

March 14, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

OMAHA, Neb., March 14, 2011 /- Transgenomic, Inc. (OTC Bulletin Board: TBIO ) today announced the completion of an expanded license with the Dana-Farber Cancer Institute, Boston, MA, for the COLD-PCR (CO-amplification at Lower Denaturing temperature PCR) technology. Previously,...

Covidien Receives FDA Approval for South African-Produced Medical Isotope Based on Low-Enriched Uranium

March 11, 2011 4:34 pm | by Covidien | News | Comments

ST. LOUIS, Mar 10, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the use of molybdenum-99 (Mo-99) derived from low-enriched uranium (LEU) in the production of...

Improvements in Pressure Sensors Help Medical Equipment Design

March 11, 2011 11:17 am | by David Ezekiel | Articles | Comments

Goals of new medical equipment design include small size, low cost, low power consumption, and a quiet user experience. Evolving technology embedded in pressure sensors and signal conditioning ICs allows for design improvements and the inclusion of new features in medical equipment. This article highlights specific examples in the design of breathing equipment and oxygen concentrators.

Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device

March 11, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

LIBERTY, Texas, March 10, 2011 /- Donna L. Jenkins filed suit today in the United States District Court in Beaumont, Texas, over a failed hip replacement system from Johnson & Johnson, Inc. and DePuy Orthopaedics that was recalled from the market.  John David Hart of the Law...

Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart

March 10, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

HOUSTON, March 10, 2011 /PRNewswire-USNewswire/ -- Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial...

Reportlinker Adds Advances in SPECT Imaging (Technical Insights)

March 9, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Advances in SPECT Imaging (Technical Insights) http://www.reportlinker.com/p0443053/Advances-in-SPECT-Imaging-Technical-Insights.html This research service evaluates the...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading